Search results for "Platelet"

showing 10 items of 786 documents

Synthesis and processing of nanocrystalline tungsten carbide: Towards cemented carbides with optimal mechanical properties

2011

Abstract Nanocrystalline tungsten carbide has been obtained by reduction/carburization at low temperature from precursors obtained by freeze-drying of aqueous solutions. Nanocrystalline WC powders with a adequate content of carbon were mixed with submicrometric Cobalt powder (12 wt.%), obtained by same synthesis method, and sintered in vacuum furnace. The cemented carbides fabricated from experimental powders were compared with both commercial ultrafine and nanocrystalline WC-12Co mixtures consolidated by the same route. The synthesised powders were characterized by X-ray powder diffraction, elemental analysis and scanning and high resolution transmission electron microscopy. On the other h…

PlateletsFreeze-drying precursorsMaterials scienceMetallurgyMechanical propertiesMicrostructureNanocrystalline materialCarbideVacuum furnacechemistry.chemical_compoundFracture toughnesschemistryNanocrystalline WCTungsten carbideHigh-resolution transmission electron microscopyCemented carbidesPowder diffractionInternational Journal of Refractory Metals and Hard Materials
researchProduct

The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep

2020

The Essential Thrombocythemia is a Chronic Philadelphia-negative Myeloproliferative Neoplasm characterized by a survival curve that is only slightly worse than that of age- and sex-adjusted healthy population. The criteria for diagnosis were reviewed in 2016 by WHO. The incidence varies from 0.2 to 2.5:100 000 people per year, with a prevalence of 38 to 57 cases per 100 000 people. The main characteristics of ET are the marked thrombocytosis and the high frequency of thrombosis. The spectrum of symptoms is quite wide, but fatigue results to be the most frequent. Thrombosis is frequently observed, often occurring before or at the time of diagnosis. The classification of thrombotic risk has …

Plateletsmedicine.medical_specialtylcsh:RC633-647.5Essential thrombocythemiabusiness.industryPlateletlcsh:Diseases of the blood and blood-forming organsHematologyReviewMyeloproliferative Neoplasmmedicine.diseaseGastroenterology03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisDigInternal medicinemedicineMyeloproliferative NeoplasmsThrombocythemiabusinessSurvival analysisMyeloproliferative neoplasm030215 immunologySlightly worse
researchProduct

Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice

2021

Acute coronary syndrome is a factor for poor prognosis and recurrent cardiovascular events. Adequate antiplatelet therapy is crucial in patients with the acute coronary syndrome for risk reduction. Such treatment is well described in four documents issued by the European Society of Cardiology, which precisely illustrate the use of antiplatelets in the settings of ST-elevated and non-ST elevated myocardial infarction. Despite its unquestioned role in the treatment of acute coronary syndrome, recent real-world-data from Polish registries reveal poor adherence to the guidelines-recommended antiplatelet treatment in Poland. Thus, we present here a comprehensive review of the use of antiplatelet…

Poor prognosismedicine.medical_specialtyAcute coronary syndromeReview Paperbusiness.industryRInvasive cardiologymedicine.diseaseantiplatelet treatmentnon-ST elevation myocardial infarctionPoor adherenceClinical PracticeST elevation myocardial infarctionmedicineMedicineIn patientNational registryMyocardial infarctionguidelinesCardiology and Cardiovascular MedicineIntensive care medicinebusinessPostępy w Kardiologii Interwencyjnej = Advances in Interventional Cardiology
researchProduct

Systemic inflammation in primary hypercholesterolemia results in platelet and leukocyte activation and their enhanced endothelial adhesiveness

2018

Primary hypercholesterolemiabusiness.industryApplied MathematicsGeneral MathematicsImmunologyMedicinePlateletmedicine.symptombusinessSystemic inflammationProceedings for Annual Meeting of The Japanese Pharmacological Society
researchProduct

Apoptosis causes lumen formation during angiogenesis in vitro.

2002

Programmed cell deathUmbilical VeinsAngiogenesisLumen (anatomy)ApoptosisBiologyBiochemistryUmbilical veinmedicineIn Situ Nick-End LabelingHumansCells CulturedNeovascularization PathologicCell BiologyIntercellular Adhesion Molecule-1ImmunohistochemistryIn vitroCell biologyEndothelial stem cellPlatelet Endothelial Cell Adhesion Molecule-1Microscopy Electronmedicine.anatomical_structureApoptosisImmunologyCollagenEndothelium VascularCardiology and Cardiovascular MedicineBlood vesselMicrovascular research
researchProduct

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia

2021

Abstract SARS-CoV-2 vaccine ChAdOx1 nCoV-19 (AstraZeneca) causes a thromboembolic complication termed vaccine-induced immune thrombotic thrombocytopenia (VITT). Using biophysical techniques, mouse models, and analysis of VITT patient samples, we identified determinants of this vaccine-induced adverse reaction. Super-resolution microscopy visualized vaccine components forming antigenic complexes with platelet factor 4 (PF4) on platelet surfaces to which anti-PF4 antibodies obtained from VITT patients bound. PF4/vaccine complex formation was charge-driven and increased by addition of DNA. Proteomics identified substantial amounts of virus production-derived T-REx HEK293 proteins in the ethyle…

ProteomicsAntigen-Antibody ComplexPlatelet Factor 4Extracellular TrapsBiochemistryEpitopesMiceSinus Thrombosis IntracranialMedicinePlateletCell Line TransformedMicroscopybiologyHematologymedicine.anatomical_structureSpike Glycoprotein CoronavirusAntibodyDrug ContaminationVirus CultivationGenetic VectorsImmunologyAdenoviridaeProinflammatory cytokineImaging Three-DimensionalImmune systemAntigenChAdOx1 nCoV-19AnimalsHumansPlatelet activationB cellAutoantibodiesInflammationPurpura Thrombocytopenic IdiopathicSARS-CoV-2business.industryCOVID-19Cell BiologyPlatelet ActivationPlatelets and ThrombopoiesisDynamic Light ScatteringHEK293 CellsImmunoglobulin GImmunologybiology.proteinCapsid ProteinsbusinessCapillary Leak SyndromePlatelet factor 4Extravasation of Diagnostic and Therapeutic MaterialsBlood
researchProduct

In Situ Detection of Phosphorylated Platelet-derived Growth Factor Receptor β Using a Generalized Proximity Ligation Method

2007

Improved methods are needed for in situ characterization of post-translational modifications in cell lines and tissues. For example, it is desirable to monitor the phosphorylation status of individual receptor tyrosine kinases in samples from human tumors treated with inhibitors to evaluate therapeutic responses. Unfortunately the leading methods for observing the dynamics of tissue post-translational modifications in situ, immunohistochemistry and immunofluorescence, exhibit limited sensitivity and selectivity. Proximity ligation assay is a novel method that offers improved selectivity through the requirement of dual recognition and increased sensitivity by including DNA amplification as a…

ProteomicsImmunoglobulinsProximity ligation assayKidneyBiochemistryReceptor tyrosine kinaseCell LineAnalytical ChemistryReceptor Platelet-Derived Growth Factor betaGrowth factor receptorPlatelet-Derived Growth Factor Receptor BetaHumansPhosphorylationMolecular BiologyWound HealingbiologyEndothelial CellsTransfectionFibroblastsImmunohistochemistryPrimary and secondary antibodiesMolecular biologyActinsCell culturebiology.proteinTyrosinePhosphorylationProtein Processing Post-TranslationalSignal TransductionMolecular & Cellular Proteomics
researchProduct

Introducing the new biomarker research approach into practice: Preliminary data from CXCL4 chemokine study in non-small cell lung cancer (NSCLC)

2012

Pulmonary and Respiratory MedicineOncologyCancer Researchmedicine.medical_specialtyOncologybusiness.industryInternal medicinemedicineBiomarker (medicine)non-small cell lung cancer (NSCLC)medicine.diseasebusinessPlatelet factor 4Lung Cancer
researchProduct

P-147PLASMA PLATELET FACTOR 4 AS PREDICTOR OF ANGIOGENIC ACTIVITY: DIAGNOSTIC AND PROGNOSTIC TOOL FOR EARLY STAGE NON-SMALL CELL LUNG CANCER

2013

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyAngiogenesisbusiness.industryCancermedicine.diseaseInternal medicinemedicineAdjuvant therapyAdenocarcinomaSurgeryStage (cooking)Cardiology and Cardiovascular MedicineLung cancerbusinessSurvival ratePlatelet factor 4Interactive CardioVascular and Thoracic Surgery
researchProduct

Evolving Risk Factors for Mortality after Lung Transplantation over the Last 10 Years: Insights from a Single-Centre Database

2016

s S233 218 (82%) patients received pooled platelet transfusion -median (IQR) 1(1-2) U. 209 (79%) and 129 (49%) patients received fresh frozen plasma (FFP) and cryoprecipitate with a median (IQR) of 3(2-4) and 0(0-0) U respectively. Conclusion: Rate and volume of transfusion of blood products compare favourably with centres performing surgery off CPB or on ECMO. Requirement for ECMO particularly for BTT, but also PGD is associated with high transfusion requirements.

Pulmonary and Respiratory MedicineTransplantationmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentSurgerySingle centresurgical procedures operativePlatelet transfusionCryoprecipitatemedicineLung transplantationSurgeryFresh frozen plasmaCardiology and Cardiovascular MedicinebusinessIntensive care medicineThe Journal of Heart and Lung Transplantation
researchProduct